The House Ways and Means Committee today held a hearing on the cost of rising prescription drug prices.
 
Committee Chairman Richard Neal, D-Mass., and Ranking Member Kevin Brady, R-Texas, said they are committed to working on bipartisan reforms to lower drug prices. “Consumers, taxpayers, employers, and our public programs like Medicare and Medicaid are all bearing the burden of years of high prices, unsustainable price increases, lack of transparency, and incentives in our government programs that too often reward high prices,” they said. “We are committed to working together to end this cycle while preserving access to life-saving innovations.”
 
Witnesses Mark Miller, executive vice president of health care at Arnold Ventures and former executive director of the Medicare Payment Advisory Commission; Rachel Sachs, associate professor of law at Washington University in St. Louis; and Joseph Antos, a scholar in health care and retirement policy at the American Enterprise Institute, proposed policy options to lower prescription drug costs in Medicare Parts B and D; while witnesses for the UAW Retiree Medical Benefits Trust and Families USA highlighted the impact of high drug costs on retirees and people with disabilities, respectively.
 
Last month, the Senate Finance Committee also launched a series of bipartisan hearings on high prescription drug prices and potential policy and oversight solutions.
 
The AHA, Federation of American Hospitals and American Society of Health-System Pharmacists recently released a report that found continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and staffing investments and identify alternative therapies. To restrain out-of-control drug prices, the AHA has recommended several options including stopping brand-name manufacturers' anticompetitive actions by addressing ever-greening and pay-for-delay practices, speeding up generic drug approvals, and passing the CREATES Act.
 

Related News Articles

Headline
The Department of Health and Human Services May 20 announced it has identified specific pricing targets for pharmaceutical manufacturers to meet to satisfy…
Headline
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation…
Headline
The White House May 12 released an executive order to reduce prescription drug costs by allowing consumers to make direct purchases from drug manufacturers at…
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription…
Headline
The Department of Commerce yesterday released notices announcing national security investigations on imports of pharmaceuticals, pharmaceutical ingredients and…
Headline
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. Court of Appeals for the 4th Circuit, urging the court to affirm a decision by the U.S. District…